Investor relations

With the marketing approval for Sedaconda (isoflurane) in 15 EU countries and a great interest in inhaled sedation and our products, Sedana Medical is well-positioned for the future.

We are well on the way to the vision of making inhaled sedation a standard therapy in critical care.

The Share

See More

Press Releases

Sedana Medical has carried out a directed share issue raising gross proceeds of 615 MSEK

Regulatory

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INT…

Sedana Medical announces intention to carry out a directed share issue of approximately 600 MSEK

Regulatory

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INT…

Sedana Medical submits IND for US clinical trials

Non-regulatory

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announces that the company has submitted an In…

View All Press Releases

Financial Calendar

SEB NORDIC Healthcare Seminar 18 January 2022 11:20
Year-End report 2021 17 February 2022 07:00

See More